Repeated miscarriage does not automatically mean that IVF is the next step: many people conceive easily, and the cause may lie in the uterus, immune-mediated clotting, thyroid function, parental chromosomes, or an individual embryo. By the end, you will know which findings make natural conception, treatment of an identified cause, or IVF with a specific type of embryo testing the more rational option.
Key takeaways
- Confirm documented losses before applying recurrent pregnancy loss criteria.
- Complete the medical work-up before deciding on IVF.
- Compare natural conception, treatment, IUI, and IVF by live-birth prospects.
- Choose embryo testing based on the suspected cause, not miscarriage count alone.
First establish whether the pattern meets recurrent pregnancy loss criteria
Two miscarriages do not automatically mean you need IVF. Infertility means difficulty achieving pregnancy; recurrent pregnancy loss means pregnancy occurs but ends repeatedly. Fertility specialists for miscarriage first confirm how many losses occurred, when they occurred, and whether each was documented by ultrasound, pathology, or a pregnancy test.
- Two losses: ASRM and ESHRE generally allow evaluation after two pregnancy losses, even if they were not consecutive. UK guidance has traditionally used three miscarriages, so your clinician may explain why the threshold differs.
- Three losses: This clearly meets the traditional recurrent-loss threshold and warrants a structured evaluation.
- Biochemical pregnancy: A positive hCG followed by a fall before an ultrasound confirms a pregnancy. Some practices record these losses; others do not include them in the formal RPL count.
- Ectopic pregnancy: It is a pregnancy loss but usually prompts separate assessment for tubal disease rather than being counted like repeated intrauterine miscarriage.
- Molar pregnancy: Abnormal placental tissue requires specialist follow-up and is not treated as ordinary RPL.
A record review comes before an IVF recommendation. Bring ultrasound reports, hCG results, pathology or pregnancy-tissue genetic reports, and treatment dates. IVF becomes relevant only after specialists determine whether the pattern reflects RPL, infertility, a chromosomal concern, or another condition; it does not automatically treat non-embryo causes such as uterine disease or antiphospholipid syndrome.
The work-up comes before a decision about IVF
IVF should follow a targeted work-up, not replace it. Recurrent pregnancy loss can result from a uterine problem, antiphospholipid syndrome, thyroid disease, a chromosome rearrangement, sperm factors, or a medical condition that IVF will not correct.
1. Review every pregnancy record, including ultrasound dates, gestational age at loss, pathology reports, and treatment. Ask whether pregnancy tissue underwent chromosomal microarray; a failed culture can make conventional karyotyping uninformative.
2. Assess the uterine cavity and shape with transvaginal ultrasound, saline infusion sonography, hysteroscopy, or another test chosen for your history. Polyps, fibroids that distort the cavity, adhesions, and a uterine septum can change treatment.
3. Test for antiphospholipid antibodies using lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. Confirmed antiphospholipid syndrome can lead to low-dose aspirin and heparin during pregnancy; do not start either without medical advice.
4. Check thyroid function, usually with thyroid-stimulating hormone, and evaluate diabetes with HbA1c when your history or risk indicates it.
5. Consider parental karyotyping after an abnormal pregnancy-tissue result, repeated losses, or a loss with no usable tissue result. A balanced chromosome rearrangement can explain losses and support discussion of PGT-SR.
6. Assess sperm with a semen analysis and review medicines, alcohol or tobacco exposure, and conditions such as diabetes, autoimmune disease, or hypertension.
Broad immune, infection, or inherited-thrombophilia panels are not routine for everyone. These findings determine whether treatment, natural conception, IUI, or recurrent pregnancy loss IVF deserves consideration.
When trying naturally, treating a cause, or using IUI makes more sense
IVF is not automatically the next step after recurrent pregnancy loss: repeated miscarriage can follow easy conception, so treating an identified cause or trying again may offer the better path.
| Option | When it makes more sense | Main limitation |
|---|---|---|
| Expectant management | Evaluation finds no clear cause, and you conceive readily | Time passes while miscarriage risk remains |
| Timed intercourse | Ovulation is predictable, sperm assessment is reassuring, and age and ovarian reserve allow more attempts | It does not overcome infertility or create embryos for testing |
| IUI | Mild male-factor infertility, unexplained infertility, or ovulation problems are present | It cannot select embryos or address a parental chromosome rearrangement |
| Treating an identified cause | Antiphospholipid syndrome, thyroid disease, diabetes, or a uterine abnormality is found | Treatment does not repair embryo chromosome errors |
| IVF | Infertility coexists with losses, ovarian reserve is reduced, age creates time pressure, or embryos need genetic testing | Retrieval may produce few or no transferable embryos, and IVF adds cost and treatment burden |
IVF becomes more reasonable when months of trying are costly because of age or declining ovarian reserve, or when a parental structural chromosome rearrangement or repeated chromosome-abnormal pregnancy losses raises a specific testing question. A chromosome result from one miscarriage can guide discussion, but it does not prove that IVF is necessary.
IVF does not correct antiphospholipid syndrome, thyroid disease, diabetes, or a uterine-cavity problem. Even IVF after miscarriage with PGT-A does not guarantee a live birth; it may reduce transfer of a known aneuploid embryo, but it has not improved cumulative live-birth rates for every patient.
Compare these paths with a specialist rather than choosing IVF solely because another loss occurred.
Choose the embryo test that matches the suspected problem
A specialist matches the test to the suspected biological problem, not simply to the fact that miscarriages have occurred. Choosing among tests is one part of IVF treatment for recurrent loss; the wrong test can add cost and delay without answering the relevant question.
| Test | What it examines | When it applies |
|---|---|---|
| PGT-A | Chromosome number, identifying many aneuploid embryos | When embryo chromosome-number errors are suspected, especially with increasing maternal age or repeated chromosomally abnormal losses |
| PGT-M | A specific single-gene disorder | When testing has identified a disease-causing parental variant, such as one responsible for an inherited condition |
| PGT-SR | Extra, missing, or rearranged chromosome material caused by a parental structural rearrangement | When a parent has a balanced translocation, inversion, or another rearrangement shown by karyotyping |
A euploid result means the tested embryo had the expected chromosome copy number in the biopsied cells; it does not rule out every genetic disorder, mosaicism elsewhere, implantation failure, placental problem, or maternal cause of miscarriage. PGT-M and PGT-SR also answer only their targeted question.
Continue with recommended prenatal screening, and discuss chorionic-villus sampling or amniocentesis when diagnostic certainty is needed.
A mosaic result shows mixed cell lines in the biopsy, not a guaranteed miscarriage or a guaranteed healthy birth; the laboratory and genetics team must interpret it. A failed biopsy or no-result embryo proves that testing was uninformative, not that the embryo is abnormal. Rebiopsy, transfer without that result, or non-use requires an individual discussion.
Use an IVF consultation to compare live-birth paths, not just embryos
An IVF consultation should compare your likely live-birth path, not simply count embryos. Fertility specialists for IVF after recurrent pregnancy loss weigh age, ovarian reserve, infertility history, expected embryo numbers, laboratory performance, cost, treatment burden, and the risk of ending with no transferable embryo.
| Option | What the comparison includes | When it applies |
|---|---|---|
| Natural conception | Time to pregnancy, age-related aneuploidy risk, miscarriage risk, and whether the evaluation found a treatable cause | A reasonable path when conception is easy, ovarian reserve is reassuring, and no separate infertility indication exists |
| IVF without PGT | Expected eggs, blastocysts, transfers, cumulative live-birth chance, and the cost and burden of stimulation and retrieval | Useful when IVF is indicated but testing is unlikely to change management |
| IVF with PGT-A | Embryo numbers after biopsy, the laboratory’s validated performance, cost per cycle, and the possibility of no euploid embryo; PGT-M or PGT-SR applies instead when a known single-gene disorder or structural rearrangement is the concern | Consider when age, embryo aneuploidy risk, or a specific genetic finding changes the balance |
A euploid PGT-A result does not guarantee a baby or eliminate miscarriage: it cannot exclude every genetic, placental, uterine, or maternal cause. Continue standard prenatal screening and discuss chorionic-villus sampling or amniocentesis when indicated.
Kore Fertility Centre can help coordinate records, ovarian-reserve results, embryology data, genetic counselling, and costs so the three paths are compared on expected live birth rather than embryo appearance alone.
Related services
Recurrent Pregnancy Loss Treatment Recurrent Pregnancy Loss Treatment at Kore Fertility Centre is designed to diagnose and manage the underlying causes of repeated miscarriages. View service → |
In Vitro Fertilization (IVF) In Vitro Fertilization (IVF) at Kore Fertility Centre is an advanced fertility treatment designed to help couples overcome infertility and achieve a... View service → |
Frequently asked questions
Do two miscarriages automatically mean I need IVF?
No. A specialist first confirms the number, timing, and documentation of the losses before recommending treatment.
What happens before deciding on IVF after recurrent pregnancy loss?
The fertility specialist completes a recurrent pregnancy loss work-up to look for causes that could change treatment.
When might trying naturally or using IUI make more sense than IVF?
Natural conception, treatment of an identified cause, or IUI can be better options when IVF does not improve the expected live-birth path.
Which embryo test is used for recurrent pregnancy loss?
The test should match the suspected problem; miscarriage history alone does not determine which embryo test is appropriate.
Related services
Preimplantation Genetic Diagnosis (PGD) Preimplantation Genetic Diagnosis (PGD) Preimplantation Genetic Diagnosis (PGD) at Kore Fertility Centre is an advanced genetic testing procedure performed during an IVF cycle to identify... View service → |
Preimplantation Genetic Testing (PGT) Preimplantation Genetic Testing (PGT) Preimplantation Genetic Testing (PGT) at Kore Fertility Centre is an advanced diagnostic procedure performed during an IVF cycle to evaluate the... View service → |
Cryopreservation Cryopreservation at Kore Fertility Centre is an advanced fertility preservation service that allows the safe freezing and storage of sperm, eggs, embryos, or... |
Keywords
